Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)
Amir Qaseem, Jennifer Yost, Itziar Etxeandia-Ikobaltzeta, George M. Abraham, Janet A. Jokela, Mary Ann Forciea, Matthew C. Miller, Linda L. Humphrey
Abstract
Practice points for clinicians developed by the American College of Physicians addressing these questions: What are the effectiveness and harms of remdesivir in hospitalized patients with coronavirus disease 2019 (COVID-19)? Do effectiveness and harms in hospitalized patients with COVID-19 vary by symptom duration, disease severity, and treatment duration?
Topics & Concepts
MedicineFamily medicineDiseaseCoronavirus disease 2019 (COVID-19)MEDLINEPandemicClinical PracticeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusHealth services research2019-20 coronavirus outbreakAlternative medicineHealth carePatient-centered careNursingIntensive care medicineCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsLong-Term Effects of COVID-19